Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III)

International Journal of Cancer. Journal International Du Cancer
Matti LehtinenGeoff Garnett

Abstract

With optimal strategy, human papillomavirus (HPV) vaccines have the potential to control HPV. We have assessed vaccine efficacy (VE), herd effect (HE) of HPV vaccination and overall protective effectiveness (PE) against high-risk HPV infections by HPV type and vaccination strategy in a community-randomized trial using the bivalent HPV16/18 vaccine. We randomized 33 communities to gender-neutral HPV vaccination (Arm A), HPV vaccination of girls and hepatitis B-virus (HBV) vaccination of boys (Arm B) and gender-neutral HBV vaccination (Arm C). Entire 1992-1995 male (40,852) and female (39,420) birth cohorts were invited, and 11,662 males and 20,513 females vaccinated with 20-30% and 45% coverage in 2007-2010. During 2010-2014, 11,396 cervicovaginal samples were collected from 13,545 18.5-year-old attendees. HPV typing was performed by a high-throughput PCR. VE was calculated for HPV vaccinated women and HE for non-HPV-vaccinated women, using the HBV vaccinated, for HE all non-HPV vaccinated, Arm C women as controls. PE was calculated as coverage rate-weighted mean of VE + HE. HPV16/18/45 and 31/33/35 VEs varied between 86-94% and 30-66%, respectively. Only the gender-neutral vaccination provided significant HEs against HPV18 (61%...Continue Reading

References

Feb 1, 1993·Journal of Clinical Epidemiology·A Donner, N Klar
Nov 25, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·G P Garnett, H C Waddell
Jan 1, 2005·The Journal of Infectious Diseases·Geoffrey P Garnett
Jan 16, 2009·Journal of Clinical Microbiology·Anna Söderlund-StrandJoakim Dillner
Oct 14, 2011·Preventive Medicine·Suzanne M GarlandJulia M L Brotherton
Dec 12, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Anna Söderlund-Strand, Joakim Dillner
Jun 6, 2013·Nature Reviews. Clinical Oncology·Matti Lehtinen, Joakim Dillner
Aug 30, 2013·Journal of Epidemiology and Community Health·Katy SinkaChris Robertson
Oct 5, 2013·The Journal of Infectious Diseases·Rebecca Howell-JonesGwenda Hughes
Feb 19, 2015·The New England Journal of Medicine·Elmar A JouraUNKNOWN Broad Spectrum HPV Vaccine Study
Feb 28, 2015·Vaccine·K Miriam ElfströmLisen Arnheim-Dahlström
May 20, 2015·BMJ : British Medical Journal·Johannes A BogaardsJohannes Berkhof
Jul 1, 2015·Lancet·Sharon J B HanleyReiko Kishi
Jul 5, 2015·The Journal of Infectious Diseases·K Miriam ElfströmIacopo Baussano
Nov 1, 2015·Mathematical Biosciences·Andrew F BrouwerMarisa C Eisenberg
Feb 6, 2016·MMWR. Surveillance Summaries : Morbidity and Mortality Weekly Report. Surveillance Summaries·Walter W WilliamsCarolyn B Bridges
Nov 7, 2016·The Journal of Infectious Diseases·Dorothy A MachalekSepehr N Tabrizi
Sep 2, 2017·The Journal of Infectious Diseases·Iacopo BaussanoSilvia Franceschi
Oct 22, 2017·International Journal of Cancer. Journal International Du Cancer·Matti LehtinenGeoffrey Garnett

❮ Previous
Next ❯

Citations

Nov 6, 2018·International Journal of Cancer. Journal International Du Cancer·Ville N PimenoffSilvia de Sanjosé
Nov 15, 2018·International Journal of Cancer. Journal International Du Cancer·Petra J WoestenbergUNKNOWN Medical Microbiological Laboratories and the Public Health Services
Jan 17, 2019·International Journal of Cancer. Journal International Du Cancer·Jiafeng PanKatie Wakeham
Nov 19, 2019·International Journal of Cancer. Journal International Du Cancer·Matti LehtinenFrank Struyf
Nov 22, 2019·International Journal of Cancer. Journal International Du Cancer·Karolina LouvantoMatti Lehtinen
Jan 28, 2020·The Journal of Infectious Diseases·Irene ManJohannes A Bogaards
Aug 23, 2018·Acta Obstetricia Et Gynecologica Scandinavica·Matti Lehtinen
Mar 13, 2020·The Journal of Infectious Diseases·Simopekka VänskäMatti Lehtinen
Apr 10, 2019·Clinical and Experimental Immunology·J WallisR C Carlisle
Nov 30, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joske HoesUNKNOWN Medical Microbiological Laboratories and Public Health Services
Dec 23, 2020·Emerging Infectious Diseases·Iacopo BaussanoGary M Clifford
Mar 9, 2021·Preventive Medicine·Tuomas LehtinenMatti Lehtinen
Jul 26, 2021·Tissue Engineering and Regenerative Medicine·Chong-Su ChoHyun-Joong Kim
Sep 10, 2021·CA: a Cancer Journal for Clinicians·Philip E CastleVikrant V Sahasrabuddhe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.